Johnson & Johnson spend $1 BILLION in coronavirus vaccine investment
A lead candidate vaccine for COVID-19 has been selected by U.S. company Johnson and Johnson on Monday.
Join our mailing list to receive a daily email with all of our top stories
PM VISION
LATEST NEWS